Reid Laurence bought MGX
September 2, 2025 · Form 4 insider transaction
Reid Laurence bought 42,000 shares of Metagenomi Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
42,000
Price
$0.00
Total value
N/A
InsiderReid Laurence
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 2, 2025
Filing dateSeptember 2, 2025
Shares owned after42,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
33% of the shares subject to this option shall vest and become exercisable on September 2, 2026, with the remainder vesting in 24 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.